Ausprunk, D. H., and J. Folkman. 1977. Migration and proliferation of endothelial
cells in preformed and newly formed blood vessels during tumor angiogenesis.
Microvasc Res 14:53-65.
2. Benjamin, L. E., I. Hemo, and E. Keshet. 1998. A plasticity window for blood
vessel remodelling is defined by pericyte coverage of the preformed endothelial
network and is regulated by PDGF-B and VEGF. Development 125:1591-8.
3. Black, R. A., S. R. Kronheim, and P. R. Sleath. 1989. Activation of interleukin-1
beta by a co-induced protease. FEBS Lett 247:386-90.
4. Blomgren, K., C. Zhu, X. Wang, J. O. Karlsson, A. L. Leverin, B. A. Bahr, C.
Mallard, and H. Hagberg. 2001. Synergistic activation of caspase-3 by m-calpain
after neonatal hypoxia-ischemia: a mechanism of "pathological apoptosis"? J Biol
Chem 276:10191-8.
5. Cai, J., J. Yang, and D. P. Jones. 1998. Mitochondrial control of apoptosis: the role
of cytochrome c. Biochim Biophys Acta 1366:139-49.
6. Cao, Y., R. Cao, and N. Veitonmaki. 2002. Kringle structures and antiangiogenesis.
Curr Med Chem Anticancer Agents 2:667-81.
7. Cao, Y., R. W. Ji, D. Davidson, J. Schaller, D. Marti, S. Sohndel, S. G. McCance,
M. S. O'Reilly, M. Llinas, and J. Folkman. 1996. Kringle domains of human
angiostatin. Characterization of the anti-proliferative activity on endothelial cells. J
Biol Chem 271:29461-7.
8. Chen, H. C., and J. L. Guan. 1994. Association of focal adhesion kinase with its
potential substrate phosphatidylinositol 3-kinase. Proc Natl Acad Sci U S A
91:10148-52.
9. Claesson-Welsh, L., M. Welsh, N. Ito, B. Anand-Apte, S. Soker, B. Zetter, M.
O'Reilly, and J. Folkman. 1998. Angiostatin induces endothelial cell apoptosis and
activation of focal adhesion kinase independently of the integrin-binding motif RGD.
Proc Natl Acad Sci U S A 95:5579-83.
10. Cooray, P., Y. Yuan, S. M. Schoenwaelder, C. A. Mitchell, H. H. Salem, and S. P.
Jackson. 1996. Focal adhesion kinase (pp125FAK) cleavage and regulation by calpain.
56
Biochem J 318 ( Pt 1):41-7.
11. Cryns, V., and J. Yuan. 1998. Proteases to die for. Genes Dev 12:1551-70.
12. Eriksson, K., P. Magnusson, J. Dixelius, L. Claesson-Welsh, and M. J. Cross. 2003.
Angiostatin and endostatin inhibit endothelial cell migration in response to FGF and
VEGF without interfering with specific intracellular signal transduction pathways.
FEBS Lett 536:19-24.
13. Fan, T. J., L. H. Han, R. S. Cong, and J. Liang. 2005. Caspase family proteases and
apoptosis. Acta Biochim Biophys Sin (Shanghai) 37:719-27.
14. Folkman, J. 1995. Angiogenesis in cancer, vascular, rheumatoid and other disease.
Nat Med 1:27-31.
15. Folkman, J. 1971. Tumor angiogenesis: therapeutic implications. N Engl J Med
285:1182-6.
16. Folkman, J. 1990. What is the evidence that tumors are angiogenesis dependent? J
Natl Cancer Inst 82:4-6.
17. Folkman, J. 1984. What is the role of endothelial cells in angiogenesis? Lab Invest
51:601-4.
18. Folkman, J., and P. A. D'Amore. 1996. Blood vessel formation: what is its molecular
basis? Cell 87:1153-5.
19. Folkman, J., and C. Haudenschild. 1980. Angiogenesis in vitro. Nature 288:551-6.
20. Folkman, J., and Y. Shing. 1992. Angiogenesis. J Biol Chem 267:10931-4.
21. Frisch, S. M., K. Vuori, E. Ruoslahti, and P. Y. Chan-Hui. 1996. Control of
adhesion-dependent cell survival by focal adhesion kinase. J Cell Biol 134:793-9.
22. Gimbrone, M. A., Jr., and R. S. Cotran. 1975. Human vascular smooth muscle in
culture. Growth and ultrastructure. Lab Invest 33:16-27.
23. Giri, D., and M. Ittmann. 1999. Inactivation of the PTEN tumor suppressor gene is
associated with increased angiogenesis in clinically localized prostate carcinoma. Hum
Pathol 30:419-24.
24. Gross, J. L., D. Moscatelli, and D. B. Rifkin. 1983. Increased capillary endothelial
cell protease activity in response to angiogenic stimuli in vitro. Proc Natl Acad Sci U
S A 80:2623-7.
57
25. Gupta, N., E. Nodzenski, N. N. Khodarev, J. Yu, L. Khorasani, M. A. Beckett, D.
W. Kufe, and R. R. Weichselbaum. 2001. Angiostatin effects on endothelial cells
mediated by ceramide and RhoA. EMBO Rep 2:536-40.
26. Hanahan, D., and J. Folkman. 1996. Patterns and emerging mechanisms of the
angiogenic switch during tumorigenesis. Cell 86:353-64.
27. Hanford, H. A., C. A. Wong, H. Kassan, D. L. Cundiff, N. Chandel, S. Underwood,
C. A. Mitchell, and G. A. Soff. 2003. Angiostatin(4.5)-mediated apoptosis of vascular
endothelial cells. Cancer Res 63:4275-80.
28. Harrington, E. O., A. Smeglin, J. Newton, G. Ballard, and S. Rounds. 2001.
Protein tyrosine phosphatase-dependent proteolysis of focal adhesion complexes in
endothelial cell apoptosis. Am J Physiol Lung Cell Mol Physiol 280:L342-53.
29. Harrington, E. O., A. Smeglin, N. Parks, J. Newton, and S. Rounds. 2000.
Adenosine induces endothelial apoptosis by activating protein tyrosine phosphatase: a
possible role of p38α. Am J Physiol Lung Cell Mol Physiol 279:L733-42.
30. Holash, J., P. C. Maisonpierre, D. Compton, P. Boland, C. R. Alexander, D.
Zagzag, G. D. Yancopoulos, and S. J. Wiegand. 1999. Vessel cooption, regression,
and growth in tumors mediated by angiopoietins and VEGF. Science 284:1994-8.
31. Hsia, D. A., S. T. Lim, J. A. Bernard-Trifilo, S. K. Mitra, S. Tanaka, J. den Hertog,
D. N. Streblow, D. Ilic, M. H. Ginsberg, and D. D. Schlaepfer. 2005. Integrin α4β1
promotes focal adhesion kinase-independent cell motility via alpha4 cytoplasmic
domain-specific activation of c-Src. Mol Cell Biol 25:9700-12.
32. Imamura, H., K. Takaishi, K. Nakano, A. Kodama, H. Oishi, H. Shiozaki, M.
Monden, T. Sasaki, and Y. Takai. 1998. Rho and Rab small G proteins coordinately
reorganize stress fibers and focal adhesions in MDCK cells. Mol Biol Cell 9:2561-75.
33. Jiang, L., V. Jha, M. Dhanabal, V. P. Sukhatme, and S. L. Alper. 2001. Intracellular
Ca2+ signaling in endothelial cells by the angiogenesis inhibitors endostatin and
angiostatin. Am J Physiol Cell Physiol 280:C1140-50.
34. Kang, C. B., L. Feng, J. Chia, and H. S. Yoon. 2005. Molecular characterization of
FK-506 binding protein 38 and its potential regulatory role on the anti-apoptotic
protein Bcl-2. Biochem Biophys Res Commun 337:30-8.
35. Kanner, S. B., A. B. Reynolds, R. R. Vines, and J. T. Parsons. 1990. Monoclonal
antibodies to individual tyrosine-phosphorylated protein substrates of
oncogene-encoded tyrosine kinases. Proc Natl Acad Sci U S A 87:3328-32.
58
36. King, A. R., S. E. Francis, C. J. Bridgeman, H. Bird, M. K. Whyte, and D. C.
Crossman. 2003. A role for caspase-1 in serum withdrawal-induced apoptosis of
endothelial cells. Lab Invest 83:1497-508.
37. Lam, E., M. Martin, and G. Wiederrecht. 1995. Isolation of a cDNA encoding a
novel human FK506-binding protein homolog containing leucine zipper and
tetratricopeptide repeat motifs. Gene 160:297-302.
38. Llinas, M., A. De Marco, S. M. Hochschwender, and R. A. Laursen. 1983. A
1H-NMR study of isolated domains from human plasminogen. Structural homology
between kringles 1 and 4. Eur J Biochem 135:379-91.
39. Lockshin, R. A., and Z. Zakeri. 2001. Programmed cell death and apoptosis: origins
of the theory. Nat Rev Mol Cell Biol 2:545-50.
40. Lopez-Ocejo, O., A. Viloria-Petit, M. Bequet-Romero, D. Mukhopadhyay, J. Rak,
and R. S. Kerbel. 2000. Oncogenes and tumor angiogenesis: the HPV-16 E6
oncoprotein activates the vascular endothelial growth factor (VEGF) gene promoter in
a p53 independent manner. Oncogene 19:4611-20.
41. Malinda, K. M., L. Ponce, H. K. Kleinman, L. M. Shackelton, and A. J. Millis.
1999. Gp38k, a protein synthesized by vascular smooth muscle cells, stimulates
directional migration of human umbilical vein endothelial cells. Exp Cell Res
250:168-73.
42. Mandic, A., J. Hansson, S. Linder, and M. C. Shoshan. 2003. Cisplatin induces
endoplasmic reticulum stress and nucleus-independent apoptotic signaling. J Biol
Chem 278:9100-6.
43. Martinon, F., K. Burns, and J. Tschopp. 2002. The inflammasome: a molecular
platform triggering activation of inflammatory caspases and processing of proIL-beta.
Mol Cell 10:417-26.
44. Maxwell, P. H., G. U. Dachs, J. M. Gleadle, L. G. Nicholls, A. L. Harris, I. J.
Stratford, O. Hankinson, C. W. Pugh, and P. J. Ratcliffe. 1997. Hypoxia-inducible
factor-1 modulates gene expression in solid tumors and influences both angiogenesis
and tumor growth. Proc Natl Acad Sci U S A 94:8104-9.
45. Mitra, S. K., D. A. Hanson, and D. D. Schlaepfer. 2005. Focal adhesion kinase: in
command and control of cell motility. Nat Rev Mol Cell Biol 6:56-68.
46. Moser, T. L., D. J. Kenan, T. A. Ashley, J. A. Roy, M. D. Goodman, U. K. Misra, D.
J. Cheek, and S. V. Pizzo. 2001. Endothelial cell surface F1-F0 ATP synthase is
59
active in ATP synthesis and is inhibited by angiostatin. Proc Natl Acad Sci U S A
98:6656-61.
47. Moser, T. L., M. S. Stack, I. Asplin, J. J. Enghild, P. Hojrup, L. Everitt, S.
Hubchak, H. W. Schnaper, and S. V. Pizzo. 1999. Angiostatin binds ATP synthase on
the surface of human endothelial cells. Proc Natl Acad Sci U S A 96:2811-6.
48. Nakagawa, T., and J. Yuan. 2000. Cross-talk between two cysteine protease families.
Activation of caspase-12 by calpain in apoptosis. J Cell Biol 150:887-94.
49. Nguyen, M., J. Folkman, and J. Bischoff. 1992. 1-Deoxymannojirimycin inhibits
capillary tube formation in vitro. Analysis of N-linked oligosaccharides in bovine
capillary endothelial cells. J Biol Chem 267:26157-65.
50. O'Reilly, M. S., L. Holmgren, C. Chen, and J. Folkman. 1996. Angiostatin induces
and sustains dormancy of human primary tumors in mice. Nat Med 2:689-92.
51. O'Reilly, M. S., L. Holmgren, Y. Shing, C. Chen, R. A. Rosenthal, M. Moses, W. S.
Lane, Y. Cao, E. H. Sage, and J. Folkman. 1994. Angiostatin: a novel angiogenesis
inhibitor that mediates the suppression of metastases by a Lewis lung carcinoma. Cell
79:315-28.
52. Pedersen, K. M., B. Finsen, J. E. Celis, and N. A. Jensen. 1999. muFKBP38: a
novel murine immunophilin homolog differentially expressed in Schwannoma cells
and central nervous system neurons in vivo. Electrophoresis 20:249-55.
53. Raser, K. J., A. Posner, and K. K. Wang. 1995. Casein zymography: a method to
study μ-calpain, m-calpain, and their inhibitory agents. Arch Biochem Biophys
319:211-6.
54. Redlitz, A., G. Daum, and E. H. Sage. 1999. Angiostatin diminishes activation of the
mitogen-activated protein kinases ERK-1 and ERK-2 in human dermal microvascular
endothelial cells. J Vasc Res 36:28-34.
55. Seo, D. W., H. Li, L. Guedez, P. T. Wingfield, T. Diaz, R. Salloum, B. Y. Wei, and
W. G. Stetler-Stevenson. 2003. TIMP-2 mediated inhibition of angiogenesis: an
MMP-independent mechanism. Cell 114:171-80.
56. Shimizu, S., and Y. Tsujimoto. 1998. [Molecular mechanism of apoptosis].
Seikagaku 70:14-21.
57. Shirane, M., and K. I. Nakayama. 2003. Inherent calcineurin inhibitor FKBP38
targets Bcl-2 to mitochondria and inhibits apoptosis. Nat Cell Biol 5:28-37.
60
58. Silverman, K. J., D. P. Lund, B. R. Zetter, L. L. Lainey, J. A. Shahood, D. G.
Freiman, J. Folkman, and A. C. Barger. 1988. Angiogenic activity of adipose tissue.
Biochem Biophys Res Commun 153:347-52.
59. Sim, B. K., N. J. MacDonald, and E. R. Gubish. 2000. Angiostatin and endostatin:
endogenous inhibitors of tumor growth. Cancer Metastasis Rev 19:181-90.
60. Soff, G. A. 2000. Angiostatin and angiostatin-related proteins. Cancer Metastasis Rev
19:97-107.
61. Takahashi, T., C. Kalka, H. Masuda, D. Chen, M. Silver, M. Kearney, M. Magner,
J. M. Isner, and T. Asahara. 1999. Ischemia- and cytokine-induced mobilization of
bone marrow-derived endothelial progenitor cells for neovascularization. Nat Med
5:434-8.
62. Tarui, T., M. Majumdar, L. A. Miles, W. Ruf, and Y. Takada. 2002.
Plasmin-induced migration of endothelial cells. A potential target for the
anti-angiogenic action of angiostatin. J Biol Chem 277:33564-70.
63. Troyanovsky, B., T. Levchenko, G. Mansson, O. Matvijenko, and L. Holmgren.
2001. Angiomotin: an angiostatin binding protein that regulates endothelial cell
migration and tube formation. J Cell Biol 152:1247-54.
64. van de Water, B., J. F. Nagelkerke, and J. L. Stevens. 1999. Dephosphorylation of
focal adhesion kinase (FAK) and loss of focal contacts precede caspase-mediated
cleavage of FAK during apoptosis in renal epithelial cells. J Biol Chem 274:13328-37.
65. Veiseth, E., S. D. Shackelford, T. L. Wheeler, and M. Koohmaraie. 2001. Effect of
postmortem storage on μ-calpain and m-calpain in ovine skeletal muscle. J Anim Sci
79:1502-8.
66. Veitonmaki, N., R. Cao, L. H. Wu, T. L. Moser, B. Li, S. V. Pizzo, B. Zhivotovsky,
and Y. Cao. 2004. Endothelial cell surface ATP synthase-triggered caspase-apoptotic
pathway is essential for k1-5-induced antiangiogenesis. Cancer Res 64:3679-86.
67. Wang, K. K. 2000. Calpain and caspase: can you tell the difference? Trends Neurosci
23:20-6.
68. Wen, L. P., J. A. Fahrni, S. Troie, J. L. Guan, K. Orth, and G. D. Rosen. 1997.
Cleavage of focal adhesion kinase by caspases during apoptosis. J Biol Chem
272:26056-61.
69. Xu, J., C. H. Yeh, S. Chen, L. He, S. L. Sensi, L. M. Canzoniero, D. W. Choi, and
61
C. Y. Hsu. 1998. Involvement of de novo ceramide biosynthesis in tumor necrosis
factor-alpha/cycloheximide-induced cerebral endothelial cell death. J Biol Chem
273:16521-6.
70. 程靜暐。不同血纖維蛋白溶酶原片段抑制血管新生能力在基因治療上的療效。國
立成功大學生物化學研究所碩士論文,2002。
71. 張文馨。血纖維蛋白溶酶原片段K420-436 和K420-448 的抗血管新生活性。國立成功
大學生物化學研究所碩士論文,2003。
72. 吳姿儀。血纖維蛋白溶酶原片段引發內皮細胞凋亡之探討。國立成功大學生物化學研究所碩士論文,2004。